| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Jun―12 |
The readiness of the spontaneous reporting system for COVID-19 vaccines safety monitoring in Croatia |
Barbara Kovačić, Morana Pavičić, Nikica Mirošević Skvrce, Siniša Tomić |
| 2 |
[GO] |
2023―Jun―12 |
Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19 |
Mustafa Dogan, Berna Yilmaz |
| 3 |
[GO] |
2023―Jun―12 |
Pharmaceutical approaches for COVID-19: An update on current therapeutic opportunities |
Sijia Fan, Hongling Wang, Dean Wu, Lu Liu |
| 4 |
[GO] |
2023―Jan―24 |
Intensive critical care and management of asthmatic and smoker patients in COVID-19 infection |
Dongming Lu, Obaid Yaqoob, Manish Kumar, Ajay Singh Kushwah, Rahul Kumar Sharma, Devinder Kumar, et al. (+2) Yogendra Mavai, Rukaiya Khan |
| 5 |
[GO] |
2022―Apr―13 |
The effectiveness of dexamethasone as a combination therapy for COVID-19 |
Nader Namazi |
| 6 |
[GO] |
2022―Apr―13 |
AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cells |
Octavio Galindo-Hernández, José Luis Vique-Sánchez |
| 7 |
[GO] |
2022―Jan―15 |
Current strategies in diagnostics and therapeutics against novel coronavirus disease (COVID-19) |
FAISAL ALOTAIBI |
| 8 |
[GO] |
2022―Jan―15 |
Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis |
OLUWAKEMI EBENEZER, OLUSOLA BODEDE, PAUL AWOLADE, MARYAM A. JORDAAN, ROPO E. OGUNSAKIN, MICHAEL SHAPI |
| 9 |
[GO] |
2022―Jan―15 |
Potential of germanium-based compounds in coronavirus infection |
VIOLETTA NAROKHA, IRYNA NIZHENKOVSKA, OLENA KUZNETSOVA |
| 10 |
[GO] |
2021―Aug―31 |
Evaluation of COVID-19 protease and HIV inhibitors interactions |
Linh Tran, Dao Ngoc Hien Tam, Heba Elhadad, Nguyen Minh Hien, Nguyen Tien Huy |
| 11 |
[GO] |
2021―Jan―23 |
Sitagliptin: a potential drug for the treatment of COVID-19? |
Sanaa K. Bardaweel, Rima Hajjo, Dima A. Sabbah |
| 12 |
[GO] |
2021―Jan―23 |
Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main protease |
Noor Atatreh, Shaima Hasan, Bassam R. Ali, Mohammad A. Ghattas |
| 13 |
[GO] |
2021―Jan―23 |
Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies |
Safa Daoud, Shada J. Alabed, Lina A. Dahabiyeh |
